ViCentra announced today that it appointed former Dexcom and Medtronic Diabetes leaders to new executive roles.

The United States Insulin Pump Market is projected to grow from US$ 1.55 billion in 2024 to US$ 2.58 billion in 2033, with a ...

Karen Baxter , former VP & GM at Dexcom with deep expertise in diabetes device commercialization across Europe, joins as SVP Sales , Europe Jay Little, ...

If you need to track your glucose daily, you probably want a pain-free option. Besides pricking your finger, there are now wearable devices that are placed on your arm and connect to an app on your ...

Among 91 women, those who used a closed-loop insulin delivery system spent an average of 65.4% of time in pregnancy-specific ...

The Global Diabetes Devices Market is projected to expand at a compound annual growth rate (CAGR) of approximately 6% by 2026. Key drivers of this growth include the rising incidence of diabetes, ...

Walmart will become the first U.S. retailer to sell Abbott’s continuous glucose monitoring device as the medtech giant looks to broaden its sales potential for its growing business unit. | Walmart ...

Medtronic (NYSE:MDT) strengthens its healthcare offerings. Key sectors of Medtronic show growth. S&P 500 futures reflects trends in healthcare. Medtronic plc (NYSE:MDT) is a global leader in medical ...

Medtronic PLC investors again failed to adequately allege the device maker’s statements about its MiniMed insulin pumps constituted securities fraud, a federal court said. The latest version of the ...

George Kelesidis, of Greece, who uses the MiniMed 780G system to manage his diabetes. [Image courtesy of Medtronic] Medtronic (NYSE:MDT) today shared three-year real-world evidence highlighting ...

The U.S. Food & Drug Administration has issued an urgent medical device correction. Specifically, an error on the t:slim X2 insulin pump has been stopping insulin ...